• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国宁夏地区肝硬化患者住院趋势的横断面研究。

Trends of hospitalisation for patients with liver cirrhosis in Ningxia, China: a cross-sectional study.

机构信息

Central Laboratory, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.

Central Laboratory, Ningxia Medical University Affiliated People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.

出版信息

BMJ Open. 2023 Aug 22;13(8):e068655. doi: 10.1136/bmjopen-2022-068655.

DOI:10.1136/bmjopen-2022-068655
PMID:37607786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10445391/
Abstract

OBJECTIVE

To evaluate the changing trends of hospitalisation for patients with liver cirrhosis between 2015 and 2019 by using hospitalisation summary records in Ningxia Hui Autonomous Region (NHAR), China.

DESIGN

A cross-sectional study.

SETTING

Hospitalisation summary records between 1 January 2015 and 31 December 2019 from 28 top-ranking hospitals in NHAR were extracted and rigorously analysed.

PARTICIPANTS

During the study period, hospitalisation records referring to liver cirrhosis were included. Records with missing data were excluded. A total of 16 566 patients with liver cirrhosis were included in this study.

OUTCOME MEASURES

International Classification of Diseases codes, tenth version (ICD-10) and text-diagnoses were used to identify hospitalisation records referring to liver cirrhosis.

RESULTS

Between 2015 and 2019, hospitalisation rates for liver cirrhosis declined from 8.38% to 5.57%. Chronic viral hepatitis accounted for almost 70% of all liver cirrhosis admissions; the remaining 30% of patients were admitted due to non-viral hepatitis cirrhosis (28.06%) and alcoholic cirrhosis (2.05%). The male-to-female hospitalisation rate ratio for liver cirrhosis was 2.57. The hospitalisation rate for workers with hepatitis cirrhosis was significantly higher than farmers (hospitalisation rate ratio (RR)=1.06, 95% CI 1.01 to 1.15, p<0.001); this was also the case for alcoholic cirrhosis (RR=5.23, 95% CI 3.34 to 8.20). However, the hospitalisation rate for workers with non-viral hepatitis cirrhosis was significantly lower than for farmers (RR=5.23, 95% CI 3.34 to 8.20, p<0.001). The hospitalisation rate increased in patients over the age of 30 years and reached a peak at the age of 45-50 years.

CONCLUSIONS

The hospitalisation rate for liver cirrhosis has declined over recent years and chronic viral hepatitis remains the major cause of liver cirrhosis in NHAR. Hospitalisation summary records can efficiently reflect the local changing trends of hospitalisation for liver cirrhosis and represent an efficient strategy for the surveillance of chronic disease.

摘要

目的

利用中国宁夏回族自治区(NHAR)住院总结记录评估 2015 年至 2019 年期间肝硬化患者住院的变化趋势。

设计

横断面研究。

设置

从 NHAR 28 家顶级医院提取并严格分析 2015 年 1 月 1 日至 2019 年 12 月 31 日期间的住院总结记录。

参与者

在研究期间,包括肝硬化住院记录。排除数据缺失的记录。共有 16566 名肝硬化患者纳入本研究。

结局指标

国际疾病分类第十版(ICD-10)和文本诊断用于识别肝硬化住院记录。

结果

2015 年至 2019 年期间,肝硬化住院率从 8.38%下降至 5.57%。慢性病毒性肝炎占所有肝硬化入院的近 70%;其余 30%的患者因非病毒性肝炎肝硬化(28.06%)和酒精性肝硬化(2.05%)入院。肝硬化的男女住院率比为 2.57。乙型肝炎肝硬化患者的住院率明显高于农民(住院率比(RR)=1.06,95%置信区间 1.01 至 1.15,p<0.001);酒精性肝硬化也是如此(RR=5.23,95%置信区间 3.34 至 8.20)。然而,非病毒性肝炎肝硬化患者的住院率明显低于农民(RR=5.23,95%置信区间 3.34 至 8.20,p<0.001)。住院率在 30 岁以上的患者中增加,并在 45-50 岁达到峰值。

结论

近年来,肝硬化的住院率有所下降,慢性病毒性肝炎仍然是 NHAR 肝硬化的主要原因。住院总结记录可以有效地反映当地肝硬化住院变化趋势,是慢性病监测的有效策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b25/10445391/62d5351685f2/bmjopen-2022-068655f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b25/10445391/9fe5181d2d2e/bmjopen-2022-068655f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b25/10445391/62d5351685f2/bmjopen-2022-068655f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b25/10445391/9fe5181d2d2e/bmjopen-2022-068655f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b25/10445391/62d5351685f2/bmjopen-2022-068655f02.jpg

相似文献

1
Trends of hospitalisation for patients with liver cirrhosis in Ningxia, China: a cross-sectional study.中国宁夏地区肝硬化患者住院趋势的横断面研究。
BMJ Open. 2023 Aug 22;13(8):e068655. doi: 10.1136/bmjopen-2022-068655.
2
Changing trends of hospitalisation of liver cirrhosis in Beijing, China.中国北京肝硬化住院治疗的变化趋势
BMJ Open Gastroenterol. 2015 Aug 27;2(1):e000051. doi: 10.1136/bmjgast-2015-000051. eCollection 2015.
3
Study of liver cirrhosis over ten consecutive years in Southern China.中国南方地区连续十年肝硬化研究。
World J Gastroenterol. 2014 Oct 7;20(37):13546-55. doi: 10.3748/wjg.v20.i37.13546.
4
Trends in the burden of hospitalised patients with cirrhosis in Switzerland: a cross-sectional study of cirrhosis-related hospitalisations between 1998 and 2020.瑞士肝硬化住院患者负担的变化趋势:1998 年至 2020 年期间肝硬化相关住院治疗的横断面研究。
BMJ Open. 2024 Aug 24;14(8):e081822. doi: 10.1136/bmjopen-2023-081822.
5
Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study.肝硬化、其他肝脏疾病与脑出血住院风险:一项基于丹麦人群的病例对照研究
BMC Gastroenterol. 2008 May 24;8:16. doi: 10.1186/1471-230X-8-16.
6
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.在澳大利亚新南威尔士州直接作用抗病毒治疗时代,丙型肝炎病毒相关肝病负担下降。
J Hepatol. 2019 Aug;71(2):281-288. doi: 10.1016/j.jhep.2019.04.014. Epub 2019 May 10.
7
Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.遗传性血色素沉着症:时间趋势、社会人口学特征及肝细胞癌的独立危险因素——基于全国人群的研究
World J Hepatol. 2022 Sep 27;14(9):1804-1816. doi: 10.4254/wjh.v14.i9.1804.
8
Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.新诊断肝硬化患者的特征、死亡率和其他结局的变化趋势。
JAMA Netw Open. 2019 Jun 5;2(6):e196412. doi: 10.1001/jamanetworkopen.2019.6412.
9
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025.到2025年,丙型肝炎相关肝硬化将成为住院治疗的一个次要病因。
J Hepatol. 2020 Dec;73(6):1360-1367. doi: 10.1016/j.jhep.2020.07.018. Epub 2020 Jul 19.
10
Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol.韩国肝硬化病因和严重程度的变化趋势:酒精的影响日益增加。
J Korean Med Sci. 2021 May 31;36(21):e145. doi: 10.3346/jkms.2021.36.e145.

引用本文的文献

1
Elevated Serum DcR3, Fas, and NLR Ratio are correlated with the progression of Liver Cirrhosis.血清DcR3、Fas水平升高及中性粒细胞与淋巴细胞比值(NLR)与肝硬化进展相关。
Am J Transl Res. 2025 Feb 15;17(2):1057-1064. doi: 10.62347/HWYM7712. eCollection 2025.

本文引用的文献

1
Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018).德国肝硬化及其并发症的趋势和病程:基于全国人口的研究(2005年至2018年)
Lancet Reg Health Eur. 2021 Nov 4;12:100240. doi: 10.1016/j.lanepe.2021.100240. eCollection 2022 Jan.
2
The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017.肝硬化及其潜在病因的负担:来自 2017 年全球疾病负担研究的结果。
Aging (Albany NY). 2021 Jan 12;13(1):279-300. doi: 10.18632/aging.104127.
3
Trends in prevalence and incidence of type 2 diabetes among adults in Beijing, China, from 2008 to 2017.
2008 年至 2017 年期间,中国北京成年人 2 型糖尿病患病率和发病率的变化趋势。
Diabet Med. 2021 Sep;38(9):e14487. doi: 10.1111/dme.14487. Epub 2021 Jan 17.
4
Surveillance of Noncommunicable Disease Epidemic Through the Integrated Noncommunicable Disease Collaborative Management System: Feasibility Pilot Study Conducted in the City of Ningbo, China.通过综合非传染性疾病协同管理系统对非传染性疾病流行进行监测:在中国宁波市进行的可行性试点研究。
J Med Internet Res. 2020 Jul 23;22(7):e17340. doi: 10.2196/17340.
5
Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China.基于中国两个缺乏癌症登记处的地区医疗保险系统的理赔数据估算癌症发病率。
EClinicalMedicine. 2020 Mar 20;20:100312. doi: 10.1016/j.eclinm.2020.100312. eCollection 2020 Mar.
6
Burden of Cirrhosis and Other Chronic Liver Diseases Caused by Specific Etiologies in China, 1990-2016: Findings from the Global Burden of Disease Study 2016.中国特定病因导致的肝硬化和其他慢性肝病负担:2016 年全球疾病负担研究的结果。
Biomed Environ Sci. 2020 Jan 20;33(1):1-10. doi: 10.3967/bes2020.001.
7
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.2017 年全球疾病负担研究:1990-2017 年 195 个国家和地区按病因划分的肝硬化全球、区域和国家负担:系统分析。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.
8
Hepatitis B infection in the general population of China: a systematic review and meta-analysis.中国普通人群中的乙型肝炎感染:系统评价和荟萃分析。
BMC Infect Dis. 2019 Sep 18;19(1):811. doi: 10.1186/s12879-019-4428-y.
9
Using health insurance reimbursement data to identify incident cancer cases.利用健康保险报销数据来识别癌症新发病例。
J Clin Epidemiol. 2019 Oct;114:141-149. doi: 10.1016/j.jclinepi.2019.06.009. Epub 2019 Jun 18.
10
Global liver disease burdens and research trends: Analysis from a Chinese perspective.全球肝脏疾病负担与研究趋势:中国视角分析。
J Hepatol. 2019 Jul;71(1):212-221. doi: 10.1016/j.jhep.2019.03.004. Epub 2019 Mar 12.